BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20635961)

  • 1. Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.
    Cobbold SP
    Immunotherapy; 2009 May; 1(3):447-60. PubMed ID: 20635961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and transplantation tolerance.
    Cobbold SP
    J Nephrol; 2008; 21(4):485-96. PubMed ID: 18651537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function and dysfunction of dendritic cells in autoimmune rheumatic diseases.
    Rutella S; De Cristofaro R; Ferraccioli G
    Hum Immunol; 2009 May; 70(5):360-73. PubMed ID: 19405176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
    Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
    Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.
    Johnson BA; Baban B; Mellor AL
    Immunotherapy; 2009 Jul; 1(4):645-61. PubMed ID: 20161103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
    Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
    Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan catabolism generates autoimmune-preventive regulatory T cells.
    Fallarino F; Grohmann U; You S; McGrath BC; Cavener DR; Vacca C; Orabona C; Bianchi R; Belladonna ML; Volpi C; Fioretti MC; Puccetti P
    Transpl Immunol; 2006 Dec; 17(1):58-60. PubMed ID: 17157218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells in health and disease: friend and foe!
    Adler HS; Steinbrink K
    Eur J Dermatol; 2007; 17(6):476-91. PubMed ID: 17951127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-dioxygenase in transplantation.
    Mulley WR; Nikolic-Paterson DJ
    Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.
    Park MJ; Park KS; Park HS; Cho ML; Hwang SY; Min SY; Park MK; Park SH; Kim HY
    Cell Immunol; 2012; 278(1-2):45-54. PubMed ID: 23121975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.
    Ikemoto T; Takita M; Levy MF; Shimada M; Naziruddin B
    Cell Immunol; 2013; 283(1-2):81-90. PubMed ID: 23933136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
    Wolfraim LA
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of indoleamine 2,3-dioxygenase on transplantation immunity].
    Duan X; Cui P; Jiang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):230-3. PubMed ID: 18365624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing immunologic tolerance for transplantation at the fetal stage.
    Mendieta-Zerón H
    Immunotherapy; 2011 Dec; 3(12):1499-512. PubMed ID: 22091685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
    Rutella S; Lemoli RM
    Immunol Lett; 2004 Jun; 94(1-2):11-26. PubMed ID: 15234530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune privilege induced by regulatory T cells in transplantation tolerance.
    Cobbold SP; Adams E; Graca L; Daley S; Yates S; Paterson A; Robertson NJ; Nolan KF; Fairchild PJ; Waldmann H
    Immunol Rev; 2006 Oct; 213():239-55. PubMed ID: 16972908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccination in autoimmune disease.
    Gross CC; Wiendl H
    Curr Opin Rheumatol; 2013 Mar; 25(2):268-74. PubMed ID: 23370378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.